Women who currently take hormone therapy, or who have taken it in the past are at increased risk of ovarian cancer,
And the risk is higher regardless of the duration of use, the formulation, estrogen dose, regimen or route of administration, according to a study.
Lina Steinrud Mørch, M.Sc., of Rigshospitalet, Copenhagen University, Denmark, found that, compared with never users, current users of HT had an overall 38 percent increased risk of ovarian cancer.
The relative risk among current HT users was 44 percent higher, with previous HT users having a 15 percent increased risk compared with women who had never used HT.
"Ovarian cancer remains highly fatal, so accordingly this risk warrants consideration when deciding whether to use HT,” the authors write.
ORGANIC SOLUTION FOR ACNE
3-Step Skinsaver System:
1. Exfoliate, 2. Unblemish, 3.Heal
Only $39.99 for 3-Month Supply
Click Here for More Information
Other news
